Trials / Unknown
UnknownNCT03746938
First in Humans to Evaluate Collagen Patches With Stem Cells in Patients With Ischemic Left Ventricular Dysfunction
First Open-label Trial in Humans to Evaluate the Safety and Efficacy of Epicardial Delivery of Collagen Patches With Adipose-derived Stem Cells in Patients With Ischemic Heart Disease and Left Ventricular Dysfunction.
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- Viscofan · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
It´s a first open-label trial in humans to evaluate the safety and efficacy of epicardial delivery of collagen patches with adipose-derived stem cells in patients with ischemic heart disease and left ventricular dysfunction that remain symptomatic despite optimal medical treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | VB-C01 | Surgical implant of VB-C01 (Collagen membrane seeded with allogeneic stem cells isolated from adipose tissue, ADSC). |
Timeline
- Start date
- 2018-11-13
- Primary completion
- 2020-10-30
- Completion
- 2020-10-30
- First posted
- 2018-11-20
- Last updated
- 2018-11-20
Locations
2 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT03746938. Inclusion in this directory is not an endorsement.